Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression

Código QR

Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression

Guardado en:

Detalles Bibliográficos
Autores principales:	Ogul E. Uner, Thonnie Rose O. See, Eszter Szalai, Hans E. Grossniklaus, Gustav Stålhammar
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/e9edc1274e1b4544ad28a850059725bb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Ogul E. Uner, et al.
Publicado: (2021)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Gustav Stålhammar
Publicado: (2020)

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Mathieu F. Bakhoum, et al.
Publicado: (2021)

Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain
por: Laura Tabuenca Del Barrio, et al.
Publicado: (2021)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Mizue Terai, et al.
Publicado: (2021)

Uveal Melanoma Metastasis
por: Ernesto Rossi, et al.
Publicado: (2021)

Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
por: Rosaria Gangemi, et al.
Publicado: (2012)

ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression
por: Yao Chen, et al.
Publicado: (2017)

Uveal melanoma: Long-term survival.
por: Tomas Radivoyevitch, et al.
Publicado: (2021)

Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients
por: Woo Seung Lee, et al.
Publicado: (2021)

PECULIARITIES OF EFFECTOR LYMPHOCYTES SUBPOPULATIONS IN PATIENTS WITH UVEAL MELANOMA DURING ACTIVATION AND CHRONIC PROGRESS OF HERPESVIRAL INFECTION
por: N. Balatskaya, et al.
Publicado: (2019)

Blood Biomarkers of Uveal Melanoma: Current Perspectives
por: Bande Rodríguez MF, et al.
Publicado: (2020)

The Economic Value of MR-Imaging for Uveal Melanoma
por: Grech Fonk L, et al.
Publicado: (2020)

Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Rino S. Seedor, et al.
Publicado: (2021)

Multiregional genetic evolution of metastatic uveal melanoma
por: Daniel A. Rodriguez, et al.
Publicado: (2021)

Current and emerging treatment options for uveal melanoma
por: Pereira PR, et al.
Publicado: (2013)

Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression
por: Mathieu F. Bakhoum, et al.
Publicado: (2021)

AMBRA1 attenuates the proliferation of uveal melanoma cells
por: Zhao Binbin, et al.
Publicado: (2021)

Molecular profiling of driver events in metastatic uveal melanoma
por: Joakim Karlsson, et al.
Publicado: (2020)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Ryota Tanaka, et al.
Publicado: (2021)

SUBPOPULATION COMPOSITION OF PERIPHERAL BLOOD LYMPHOCYTES IN UVEAL MELANOMA
por: Svetlana Vladimirovna Saakyan, et al.
Publicado: (2019)

Punctuated evolution of canonical genomic aberrations in uveal melanoma
por: Matthew G. Field, et al.
Publicado: (2018)

Posterior uveal melanoma in adolescents and children: current perspectives
por: Fry MV, et al.
Publicado: (2018)

Uveal melanoma: epidemiology, etiology, and treatment of primary disease
por: Krantz BA, et al.
Publicado: (2017)

Anticancer effects of mifepristone on human uveal melanoma cells
por: Prisca Bustamante Alvarez, et al.
Publicado: (2021)

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
por: Lars Ny, et al.
Publicado: (2021)

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
por: Manuel Rodrigues, et al.
Publicado: (2018)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Jan Pals, et al.
Publicado: (2021)

Irreversible electroporation of human primary uveal melanoma in enucleated eyes.
por: Yossi Mandel, et al.
Publicado: (2013)

No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter
por: Shiva Sabazade, et al.
Publicado: (2021)

Radiological Patterns of Uveal Melanoma Liver Metastases in Correlation to Genetic Status
por: Serdar Yavuzyigitoglu, et al.
Publicado: (2021)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington BY, et al.
Publicado: (2018)

Single-cell analysis reveals new evolutionary complexity in uveal melanoma
por: Michael A. Durante, et al.
Publicado: (2020)

Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland
por: Samir Aziz, et al.
Publicado: (2008)

CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma.
por: Xueying Shi, et al.
Publicado: (2021)

Uveal melanoma incidentally diagnosed with neuroimaging, a case series of 3 patients
por: Mai Tsukikawa, MD, et al.
Publicado: (2022)

Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses
por: Aaberg Jr TM, et al.
Publicado: (2014)

Combination of oridonin and TRAIL induces apoptosis in uveal melanoma cells by upregulating DR5
por: Xin Hua, et al.
Publicado: (2021)

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
por: Peter A. Johansson, et al.
Publicado: (2020)

A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus
por: Lenha Mobuchon, et al.
Publicado: (2017)